Bacq Y, Sapey T, Bréchot MC, Pierre F, Fignon A, and Dubois F. Intrahepatic cholestasis of pregnancy: A French prospective study. Hepatology 1997; 26:358-364.
Bacq Y, Myara A, Brechot MC, Hamon C, Studer E, Trivin F, and Metman EH. Serum conjugated bile acid profile during intrahepatic cholestasis of pregnancy. J.Hepatol. 1995; 22:66-70.
Brites D, Rodrigues CM, Oliveira N, Cardoso MD, and Graça LM. Correction of maternal serum bile acid profile during ursodeoxycholic acid therapy in cholestasis of pregnancy. J.Hepatol. 1998; 28:91-98.
Brites D, Rodrigues CM, Cardoso MD, and Graça LM. Unusual case of severe cholestasis of pregnancy with early onset, improved by ursodeoxycholic acid administration. Eur.J.Obstet.Gynecol.Reprod.Biol. 1998; 76:165-168.
Davies MH, Da Silva RCMA, Jones SR, Weaver JB, and Elias E. Fetal mortality associated with cholestasis of pregnancy and the potential benefit of therapy with ursodeoxycholic acid. Gut 1995; 37:580-584.
Davies MH, Ngong JM, Yucesoy M, Acharya SK, Mills CO, Weaver JB, Waring RH, and Elias E. The adverse influence of pregnancy upon sulphation: A clue to the pathogenesis of intrahepatic cholestasis of pregnancy? J.Hepatol. 1994; 21:1127-1134.
Diaferia A, Nicastri PL, Tartagni M, Loizzi P, Iacovizzi C, and Di Leo A. Ursodeoxycholic acid therapy in pregnant women with cholestasis. Int.J.Gynecol.Obstet. 1996; 52:133-140.
Floreani A, Paternoster D, Melis A, and Grella PV. S-adenosylmethionine versus ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy: Preliminary results of a controlled trial. Eur.J.Obstet.Gynecol.Reprod.Biol. 1996; 67:109-113.
Floreani A, Paternoster D, Grella V, Sacco S, and Gangemi M. Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy. Br.J.Obstet.Gynaecol. 1994; 101:64-65.
Frezza M, Pozzato G, Chiesa L, Stramentinoli G, and DiPadova CC. Reversal of intrahepatic cholestasis of pregnancy in women after high dose S-adenosyl-L-methionine administration. Hepatology 1984; 4:274-278.
Gonzalez MC, Iglesias J, Tiribelli C, Ribalta J, Reyes H, Hernandez I, Bianchi M, Andrighetti F, and Molina C. Epomediol ameliorates pruritus in patients with intrahepatic cholestasis of pregnancy. J.Hepatol. 1992; 16:241-250.
Gonzalez MC, Reyes H, Arrese M, and et al. Intrahepatic cholestasis of pregnancy in twin pregnancies. J.Hepatol. 1989; 9:84-90.
Heikinnen J, Maentausta O, Ylostalo P, and Janne O. Serum bile acid levels in intrahepatic cholestasis of pregnancy during treatment with phenobarbital or cholestyramine. Eur.J.Obstet.Gynecol.Reprod.Biol. 1982; 14:153-162.
Hirvioja ML and Kivinen S. Inheritance of intrahepatic cholestasis of pregnancy in one kindred. Clin.Genet. 1993; 43:315-317.
Hirvioja ML, Tuimala R, and Vuori J. The treatment of intrahepatic cholestasis of pregnancy by dexamethasone. Br.J.Obstet.Gynaecol. 1992; 99:109-111.
Kauppila A, Korpela H, Maekilae UM, and Yrjaenheikki E. Low serum selenium concentration and glutathione peroxidase activity in intrahepatic cholestasis of pregnancy. Br.Med.J. 1987; 294:150-152.
Kirkinen P and Ryynänen M. First-trimester manifestation of intrahepatic cholestasis of pregnancy and high fetoplacental hormone production in a triploid fetus: A case report. J.Reprod.Med. 1995; 40:471-473.
Leevy CB, Koneru B, and Klein KM. Recurrent familial prolonged intrahepatic cholestasis of pregnancy associated with chronic liver disease. Gastroenterology 1997; 113:966-972.
Lunzer M, Barnes P, Byth K, and O'Halloran M. Serum bile acid concentrations during pregnancy and their relationship to obstetric cholestasis. Gastroenterology 1986; 91:825-829.
Mella JG, Roschmann E, Glasinovic JC, Alvarado A, Scrivanti M, and Volk BA. Exploring the genetic role of the HLA-DPB1 locus in Chileans with intrahepatic cholestasis of pregnancy. J.Hepatol. 1996; 24:320-323.
Meng LJ, Reyes H, Palma J, Hernandez I, Ribalta J, and Sjövall J. Profiles of bile acids and progesterone metabolites in the urine and serum of women with intrahepatic cholestasis of pregnancy. J.Hepatol. 1997; 27:346-357.
Meng LJ, Reyes H, Palma J, Hernandez I, Ribalta J, and Sjövall J. Effects of ursodeoxycholic acid on conjugated bile acids and progesterone metabolites in serum and urine of patients with intrahepatic cholestasis of pregnancy. J.Hepatol. 1997; 27:1029-1040.
Meng LJ, Reyes H, Axelson M, Palma J, Hernandez I, Ribalta J, and Sjövall J. Progesterone metabolites and bile acids in serum of patients with intrahepatic cholestasis of pregnancy: Effect of ursodeoxycholic acid therapy. Hepatology 1997; 26:1573-1579.
Olsson R, Tysk C, Aldenborg F, and Holm B. Prolonged postpartum course of intrahepatic cholestasis of pregnancy. Gastroenterology 1993; 105:267-271.
Palma J, Reyes H, Ribalta J, Hernández I, Sandoval L, Almuna R, Liepins J, Lira F, Sedano M, Silva O, Tohá D, and Silva JJ. Ursodeoxycholic acid in the treatment of cholestasis of pregnancy: a randomized, double-blind study controlled with placebo. J.Hepatol. 1997; 27:1022-1028.
Palma J, Reyes H, Ribalta J, Iglesias J, Gonzalez MC, Hernandez I, Alvarez C, Molina C, and Danitz AM. Effects of ursodeoxycholic acid in patients with intrahepatic cholestasis of pregnancy. Hepatology 1992; 15:1043-1047.
Reyes H, Wegmann ME, Segovia N, Cuchacovich M, Jadresic E, Contador M, Fuentes C, and Melendez M. HLA in Chileans with intrahepatic cholestasis of pregnancy. Hepatology 1982; 2:463-466.
Reyes H, Gonzalez MC, Ribalta J, Aburto H, Matus C, Schramm G, Katz R, and Medina E. Prevalence of intrahepatic cholestasis of pregnancy in Chile. Ann.Intern.Med. 1978; 88:487-493.
Reyes H, Ribalta J, Gonzalez MC, Segovia N, and Oberhauser E. Sulfobromophthalein clearance tests before and after ethinyl estradiol administration in women and men with familial history of intrahepatic cholestasis of pregnancy. Gastroenterology 1981; 81:226-231.
Ribalta J, Reyes H, Gonzalez MC, Iglesias J, Arrese M, Poniachik J, Molina C, and Segovia N. S-Adenosyl-L-Methionine in the treatment of patients with intrahepatic cholestasis of pregnancy: a randomized- double-blind- placebo-controlled study with negative results. Hepatology 1991; 13:1084-1089.
Rioseco AJ, Ivankovic MB, Manzur A, Hamed F, Kato SR, Parer JT, and Germain AM. Intrahepatic cholestasis of pregnancy - a retrospective case- control study of perinatal outcome. Am.J.Obstet.Gynecol. 1994; 170:890-895.
Roger D, Vaillant L, Fignon A, Pierre F, Bacq Y, Brechot JF, Grangeponte MC, and Lorette G. Specific pruritic diseases of pregnancy - a prospective study of 3192 pregnant women. Arch.Dermatol. 1994; 130:734-739.
Shaw D, Frohlich J, Wittmann BK, and Willms M. A prospective study of 18 patients with cholestasis of pregnancy. Am.J.Obstet.Gynecol. 1982; 142:621-625.
Sjoevall L and Sjoevall J. Serum bile acid levels in pregnancy with pruritus. Clin.Chim.Acta 1966; 13:207-211.
Ylostalo P, Kirkinen P, Heikkinen J, Maentausta O, and Jarvinen P. Gallbladder volume and serum bile acids in cholestasis of pregnancy. Br.J.Obstet.Gynaecol. 1982; 89:59-61.
Jacquemin E, Cresteil D, Manouvrier S, Boute O and Hadchouel M. Heterozygous non-sense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancy. Lancet 1999; 353: 210-211.
Dixon PH, Weerasekera n, Linton KJ et al. Heterozygous MDR3 missense mutation associated with intrahepatic cholestasis of pregnancy: evidence for a defect in protein trafficking. Human Mol Gen 2000; 9_ 1209-1217.
Reyes H, Baez ME, Gonzalez MC et al. Selenium, zinc and copper plasma levels in intrahepatic cholestasis of pregnancy, in normal pregnancies and in healthy individuals, in Chile. J Hepatol 2000; 32: 532-549.
Reyes H, Sjovall J. Bile acids and progesterone metabolites in intrahepatic cholestasis of pregnancy. Ann Med 2000; 32: 94-106.
Lammert F, Marschall HU, Glantz A, Matern S. Intrahepatic cholestasis of pregnancy: Molecular pathogenesis, diagnosis and management. J Hepatol 2000; 33: 1012-1021 (Recommended review).
Mazella G, Nicola R, Francesco A et al. Ursodeoxycholic acid administration in patients with cholestasis of pregnancy: Effects on primary bile acids in babies and mothers. Hepatology 2001; 33: 504-508.
Kenyon AP, Piercy CN, Girling J et al. Pruritus may precede abnormal liver function tests in pregnant women with obstetric cholestasis: a longitudinal analysis. Br J Obstet Gynaecol 2001; 108: 1190-1192.
Eloranta ML, Heiskanen JT, Hiltunen MJ et al. Multidrug resistance 3 gene mutation 1712delT and estrogen receptor a gene polymorphisms in Finnish women with obstetric cholestasis. Eur J Obstet Gynecol 2002; 104: 109-112.
Glantz A, Marschall HU & Mattsson LA. Intrahepatic cholestasis of pregnancy: Relationships between bile acid levels and fetal complication rates. Hepatology 2004; 40:467-474.